ROLR
High Roller Technologies, Inc.
Gambling, Resorts & Casinos
Market Cap$57M
5Y Perf.—
Build Your Comparison
Side-by-side financial analysisROLR
GENI
JPM
Try popular comparisons:
Stock Comparison
ROLR vs GENI vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
GENI
Genius Sports Limited
Internet Content & Information
Market Cap$1.76B
5Y Perf.-10.1%
JPM
JPMorgan Chase & Co.
Banks - Diversified
Market Cap$896.00B
5Y Perf.+42.7%
ROLR vs GENI vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot |  ROLR |  GENI |  JPM |
|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Internet Content & Information | Banks - Diversified |
| Market Cap | $57M | $1.76B | $896.00B |
| Revenue (TTM) | $17M | $713M | $280.33B |
| Net Income (TTM) | $1M | $-159M | $57.05B |
| Gross Margin | 49.6% | 22.6% | 60.0% |
| Operating Margin | -34.5% | -18.3% | 25.9% |
| Forward P/E | 17.6x | — | 14.4x |
| Total Debt | $807K | $30M | $942.38B |
| Cash & Equiv. | $2M | $281M | $343.34B |
ROLR vs GENI vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
ROLR
GENI
JPM
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| High Roller Technol… (ROLR) | 100 | Infinity | +Infinity% |
| Genius Sports Limit… (GENI) | 100 | 89.9 | -10.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 142.7 | +42.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ROLR vs GENI vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: JPM leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. High Roller Technologies, Inc. is the stronger pick specifically for recent price momentum and sentiment and operational efficiency and capital deployment. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
ROLR
High Roller Technologies, Inc.
The Value Pick
ROLR is the clearest fit if your priority is valuation efficiency.
- PEG 0.16 vs JPM's 0.81
- +137.8% vs GENI's -34.6%
- 4.6% ROA vs GENI's -15.4%, ROIC -119.9% vs -16.6%
Best for: valuation efficiency
GENI
Genius Sports Limited
The Growth Play
GENI is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- Lower volatility, beta 1.59, Low D/E 4.2%, current ratio 1.56x
- Beta 1.59, current ratio 1.56x
Best for: growth exposure and sleep-well-at-night
JPM
JPMorgan Chase & Co.
The Banking Pick
JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- 465.8% 10Y total return vs GENI's -31.5%
- Better valuation composite
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth |  GENI | 31.0% revenue growth vs ROLR's -26.6% |
| Value |  JPM | Better valuation composite |
| Quality / Margins | JPM | 20.4% margin vs GENI's -22.3% |
| Stability / Safety | JPM | Beta 0.94 vs ROLR's 2.73 |
| Dividends | JPM | 1.9% yield; 15-year raise streak; the other 2 pay no meaningful dividend |
| Momentum (1Y) |  ROLR | +137.8% vs GENI's -34.6% |
| Efficiency (ROA) | ROLR | 4.6% ROA vs GENI's -15.4%, ROIC -119.9% vs -16.6% |
ROLR vs GENI vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
FY 2025
ROLR vs GENI vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLJPMLAGGINGROLR
ROLRHigh Roller Technolog…
0leads
GENIGenius Sports Limited
1leads
JPMJPMorgan Chase & Co.
5leads
6 Total Categories
CATEGORYLEADERvs GENIvs ROLRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
JPM4/6
Valuation MetricsMultiples, price ratios, and targets
GENI3/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
JPM5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
JPM4/6
Risk & VolatilityBeta, volatility, and downside exposure
JPM2/2
Analyst OutlookRatings, price targets, and dividends
JPM1/1
Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 16443.7x ROLR's $17M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to GENI's -22.3%. On growth, GENI holds the edge at +30.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| RevenueTrailing 12 months | $17M | $713M | $280.3B |
| EBITDAEarnings before interest/tax | -$6M | -$54M | $81.4B |
| Net IncomeAfter-tax profit | $1M | -$159M | $57.0B |
| Free Cash FlowCash after capex | -$3M | $16M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +49.6% | +22.6% | +60.0% |
| Operating MarginEBIT ÷ Revenue | -34.5% | -18.3% | +25.9% |
| Net MarginNet income ÷ Revenue | +5.9% | -22.3% | +20.4% |
| FCF MarginFCF ÷ Revenue | -17.2% | +2.2% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -50.3% | +30.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +25.6% | -6.0% | +16.0% |
JPM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
GENI leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 9% valuation discount to ROLR's 17.6x P/E. Adjusting for growth (PEG ratio), ROLR offers better value at 0.16x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Market CapShares × price | $57M | $1.8B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $56M | $1.5B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 17.64x | -15.57x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | 0.16x | — | 0.90x |
| EV / EBITDAEnterprise value multiple | — | — | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 2.63x | 3.20x |
| Price / BookPrice ÷ Book value/share | 6.36x | 2.41x | 2.47x |
| Price / FCFMarket cap ÷ FCF | — | 27.33x | 8.88x |
GENI leads this category, winning 3 of 5 comparable metrics.
Profitability & Efficiency
JPM leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-22 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), JPM scores 5/9 vs GENI's 3/9, reflecting solid financial health.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| ROE (TTM)Return on equity | +7.9% | -22.2% | +15.9% |
| ROA (TTM)Return on assets | +4.6% | -15.4% | +1.3% |
| ROICReturn on invested capital | -119.9% | -16.6% | +4.5% |
| ROCEReturn on capital employed | -63.7% | -15.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 |
| Debt / EquityFinancial leverage | 0.08x | 0.04x | 2.60x |
| Net DebtTotal debt minus cash | -$1M | -$250M | $599.0B |
| Cash & Equiv.Liquid assets | $2M | $281M | $343.3B |
| Total DebtShort + long-term debt | $807,000 | $30M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | -17.49x | -75.96x | 0.74x |
JPM leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
JPM leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $3,776 for GENI. Over the past 12 months, ROLR leads with a +137.8% total return vs GENI's -34.6%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs GENI's 4.3% — a key indicator of consistent wealth creation.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| YTD ReturnYear-to-date | +190.0% | -36.5% | -0.5% |
| 1-Year ReturnPast 12 months | +137.8% | -34.6% | +21.8% |
| 3-Year ReturnCumulative with dividends | — | +13.4% | +138.2% |
| 5-Year ReturnCumulative with dividends | — | -62.2% | +118.2% |
| 10-Year ReturnCumulative with dividends | — | -31.5% | +465.8% |
| CAGR (3Y)Annualised 3-year return | — | +4.3% | +33.6% |
JPM leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
JPM leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
JPM is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than ROLR's 2.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs ROLR's 18.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.73x | 1.59x | 0.94x |
| 52-Week HighHighest price in past year | $33.68 | $13.73 | $337.25 |
| 52-Week LowLowest price in past year | $1.16 | $3.83 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +18.9% | +49.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 73.2 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 5.4M | 7.0M |
JPM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
JPM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: GENI as "Buy", JPM as "Buy". Consensus price targets imply 37.2% upside for GENI (target: $9) vs 5.9% for JPM (target: $340). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.
| Metric | ROLRHigh Roller Techn… | GENIGenius Sports Lim… | JPMJPMorgan Chase & … |
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy |
| Price TargetConsensus 12-month target | — | $9.40 | $339.75 |
| # AnalystsCovering analysts | — | 19 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.9% |
| Dividend StreakConsecutive years of raises | — | 1 | 15 |
| Dividend / ShareAnnual DPS | — | — | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +3.9% |
JPM leads this category, winning 1 of 1 comparable metric.
Key Takeaway
JPM leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GENI leads in 1 (Valuation Metrics).
Best OverallJPMorgan Chase & Co. (JPM)Leads 5 of 6 categories
Loading custom metrics...
ROLR vs GENI vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ROLR or GENI or JPM a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -26. 6% for High Roller Technologies, Inc. (ROLR). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Genius Sports Limited (GENI) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ROLR or GENI or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus High Roller Technologies, Inc. at 17. 6x.
03Which is the better long-term investment — ROLR or GENI or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -62. 2% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: JPM returned +465. 8% versus GENI's -31. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ROLR or GENI or JPM?
By beta (market sensitivity over 5 years), JPMorgan Chase & Co.
(JPM) is the lower-risk stock at 0. 94β versus High Roller Technologies, Inc. 's 2. 73β — meaning ROLR is approximately 189% more volatile than JPM relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — ROLR or GENI or JPM?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -26. 6% for High Roller Technologies, Inc. (ROLR). On earnings-per-share growth, the picture is similar: High Roller Technologies, Inc. grew EPS 143. 9% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ROLR or GENI or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -27. 8% for ROLR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ROLR or GENI or JPM more undervalued right now?
Analyst consensus price targets imply the most upside for GENI: 37.
2% to $9. 40.
08Which pays a better dividend — ROLR or GENI or JPM?
In this comparison, JPM (1.
9% yield) pays a dividend. ROLR, GENI do not pay a meaningful dividend and should not be held primarily for income.
09Is ROLR or GENI or JPM better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). High Roller Technologies, Inc. (ROLR) carries a higher beta of 2. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ROLR and GENI and JPM?
These companies operate in different sectors (ROLR (Consumer Cyclical) and GENI (Communication Services) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ROLR is a small-cap deep-value stock; GENI is a small-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while ROLR, GENI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.